Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12605000279628
Ethics application status
Approved
Date submitted
1/09/2005
Date registered
2/09/2005
Date last updated
2/09/2005
Type of registration
Retrospectively registered
Titles & IDs
Public title
Interventions to improve participation in bowel cancer screening: the value of lay advocacy and positive framing of risk.
Query!
Scientific title
Interventions to improve participation in bowel cancer screening: the value of lay advocacy and positive framing of risk.
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Screening for bowel cancer
367
0
Query!
Condition category
Condition code
Cancer
430
430
0
0
Query!
Bowel - Anal
Query!
Cancer
431
431
0
0
Query!
Bowel - Back passage (rectum) or large bowel (colon)
Query!
Cancer
432
432
0
0
Query!
Bowel - Small bowel (duodenum and ileum
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Intervention 1: the use of a bowel cancer screening invitation letter to that contains photographs of 2 previous screenees who were diagnosed with early bowel cancer through their participation in a bowel cancer screening program, and with simple program advocacy statements from them.
Intervention 2: the use of a bowel cancer screening invitation letter that contains enhanced positive framing and generalised risk messages.
Query!
Intervention code [1]
330
0
Behaviour
Query!
Comparator / control treatment
Control: A generic invitation letter
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
493
0
Completion of faecal immunochemical test within 12 weeks of offer
Query!
Assessment method [1]
493
0
Query!
Timepoint [1]
493
0
Query!
Secondary outcome [1]
1058
0
Test positivity rate
Query!
Assessment method [1]
1058
0
Query!
Timepoint [1]
1058
0
Query!
Secondary outcome [2]
1059
0
Yield of neoplasia
Query!
Assessment method [2]
1059
0
Query!
Timepoint [2]
1059
0
Query!
Eligibility
Key inclusion criteria
Present on the electoral roll of the Australian Electoral Commission, who reside in one of a set of defined postcodes adjacent to Flinders Medical Centre or Repatriation General Hospital Daw Park.
Query!
Minimum age
50
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
People already participating in bowel cancer screening research and service programs coordinated from the Bowel Health Service, Repatriation General Hospital Daw Park.Self exclusion by invitees - people who have specific heart and lung conditions that would preclude them from diagnostic and surgical follow-up following a positive screening test. All people who have specific medical conditions that would invalidate the screening test results. All people who have had a colonoscopy or stool screening test within the last year.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Invitees are randomised to one of three screening programs differing in intvitation content. Allocation to invitation group is not concealed from the investigators and office staff who print and package invitation kits for postal delivery, but there is no direct contact netween investigators and invitees. Invitees are unaware that there are more than one invitation type. A help line is available and inquiries are answered without knowledge of invitation type.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Group sizes of 600 each were determined by power analysis assuming that an intervention that produces a 10% increase in participation over control is a significant program improvement. All eligible people were assigned a random number using the MicroSoft Excel RAND function. The listing was ordered by ascending random number. The first 600 people were assigned to the intervention group 1 (Lay advocacy), the second 600 to Intervention group 2 (risk framing) and the third 600 to the control group.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Date of first participant enrolment
Anticipated
1/01/2005
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
1800
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
482
0
Government body
Query!
Name [1]
482
0
NHMRC project grant 187644
Query!
Address [1]
482
0
Query!
Country [1]
482
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Prof. Graeme Young MD, FRACP
Query!
Address
Query!
Country
Query!
Secondary sponsor category [1]
389
0
Individual
Query!
Name [1]
389
0
Mr Stephen Cole
Query!
Address [1]
389
0
Query!
Country [1]
389
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
1461
0
Repatriation General Hospital Daw Park
Query!
Ethics committee address [1]
1461
0
Daws Rd, Daw Park, SA 5041
Query!
Ethics committee country [1]
1461
0
Australia
Query!
Date submitted for ethics approval [1]
1461
0
Query!
Approval date [1]
1461
0
Query!
Ethics approval number [1]
1461
0
Query!
Summary
Brief summary
Improved participation in screening for bowel cancer is desirable. Currently population scale bowel cancer screening program delivery is by mailed offer from a central screening service and invitations include a faecal occult blood detection kit. Invitees may decline the offer because they do not feel they are at risk, or because they do not engage with the program. We have developed invitation letters to that include either improved risk messages or messages from previous screening participants in order to overcome these barriers. We will randomly select invitees from the electoral roll and compare population screening participation between groups with or without the preliminary letter to determine which program results in the greater participation rate. Improved participation in screening will ultimately reduce deaths from bowel cancer
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
36228
0
Query!
Address
36228
0
Query!
Country
36228
0
Query!
Phone
36228
0
Query!
Fax
36228
0
Query!
Email
36228
0
Query!
Contact person for public queries
Name
9519
0
Ms Alicia Smith
Query!
Address
9519
0
Bowel Health Service
Repatriation General Hospital Daw Park
Daws Rd
Daw Park SA 5041
Query!
Country
9519
0
Australia
Query!
Phone
9519
0
+61 8 82751075
Query!
Fax
9519
0
Query!
Email
9519
0
[email protected]
Query!
Contact person for scientific queries
Name
447
0
Mr Stephen Cole
Query!
Address
447
0
Bowel Health Service
Repatriation General Hospital Daw Park
Daws Road
Daw Park SA 5041
Query!
Country
447
0
Australia
Query!
Phone
447
0
+61 8 82751838
Query!
Fax
447
0
+61 8 82751083
Query!
Email
447
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF